$79.90M Market Cap.
CHCI Market Cap. (MRY)
CHCI Shares Outstanding (MRY)
CHCI Assets (MRY)
Total Assets
$64.87M
Total Liabilities
$12.50M
Total Investments
$6.23M
CHCI Income (MRY)
Revenue
$51.29M
Net Income
$14.56M
Operating Expense
$2.38M
CHCI Cash Flow (MRY)
CF Operations
$10.68M
CF Investing
-$350.00K
CF Financing
-$352.00K
CHCI Dividends (MRY)
Period | Dividends | Yield % | Growth % | Payout Ratio | Coverage Ratio |
|---|---|---|---|---|---|
2024 | $0 | 0% | 0% | 0% | - |
2023 | $0 | 0% | 0% | 0% | - |
2022 | $0 | 0% | 0% | 0% | - |
2021 | $0 | 0% | 0% | 0% | - |
2020 | $0 | 0% | - | 0% | - |
CHCI Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $64,867,000 (29.89%) | $49,939,000 (17.58%) | $42,473,000 (-2.59%) | $43,602,000 (52.57%) |
Assets Current | $36,727,000 (50.61%) | $24,386,000 (54.53%) | $15,781,000 (-21.39%) | $20,076,000 (62.89%) |
Assets Non-Current | $28,140,000 (10.12%) | $25,553,000 (-4.27%) | $26,692,000 (13.46%) | $23,526,000 (44.74%) |
Goodwill & Intangible Assets | $144,000 (0.00%) | $144,000 (0.00%) | $144,000 (0%) | $0 (0%) |
Shareholders Equity | $52,369,000 (40.72%) | $37,216,000 (28.98%) | $28,854,000 (14.07%) | $25,296,000 (125.56%) |
Property Plant & Equipment Net | $6,550,000 (-10.97%) | $7,357,000 (-9.90%) | $8,165,000 (8.74%) | $7,509,000 (-7.11%) |
Cash & Equivalents | $28,761,000 (53.08%) | $18,788,000 (60.28%) | $11,722,000 (-25.92%) | $15,823,000 (125.01%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $6,228,000 (-12.00%) | $7,077,000 (0.91%) | $7,013,000 (49.15%) | $4,702,000 (-25.45%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $6,228,000 (-12.00%) | $7,077,000 (0.91%) | $7,013,000 (49.15%) | $4,702,000 (-25.45%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $7,536,000 (43.68%) | $5,245,000 (38.21%) | $3,795,000 (117.73%) | $1,743,000 (-51.98%) |
Trade & Non-Trade Payables | $781,000 (-6.80%) | $838,000 (12.94%) | $742,000 (-5.24%) | $783,000 (-8.31%) |
Accumulated Retained Earnings (Deficit) | -$147,770,000 (8.97%) | -$162,330,000 (4.58%) | -$170,114,000 (5.23%) | -$179,507,000 (7.05%) |
Tax Assets | $14,720,000 (35.23%) | $10,885,000 (-4.14%) | $11,355,000 (0.49%) | $11,300,000 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $6,273,000 (-11.98%) | $7,127,000 (-9.99%) | $7,918,000 (-38.43%) | $12,861,000 (-4.27%) |
Debt Current | $922,000 (7.96%) | $854,000 (7.96%) | $791,000 (28.41%) | $616,000 (7.32%) |
Debt Non-Current | $5,351,000 (-14.70%) | $6,273,000 (-11.98%) | $7,127,000 (-41.80%) | $12,245,000 (-4.79%) |
Total Liabilities | $12,498,000 (-1.77%) | $12,723,000 (-6.58%) | $13,619,000 (-25.60%) | $18,306,000 (5.43%) |
Liabilities Current | $6,655,000 (4.42%) | $6,373,000 (-1.83%) | $6,492,000 (7.11%) | $6,061,000 (34.60%) |
Liabilities Non-Current | $5,843,000 (-7.98%) | $6,350,000 (-10.90%) | $7,127,000 (-41.80%) | $12,245,000 (-4.79%) |
CHCI Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $51,294,000 (14.70%) | $44,721,000 (13.76%) | $39,313,000 (26.44%) | $31,093,000 (38.27%) |
Cost of Revenue | $38,630,000 (16.92%) | $33,040,000 (12.49%) | $29,371,000 (19.16%) | $24,649,000 (33.64%) |
Selling General & Administrative Expense | $2,075,000 (-9.98%) | $2,305,000 (29.20%) | $1,784,000 (38.83%) | $1,285,000 (-2.21%) |
Research & Development Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Expenses | $2,377,000 (-5.56%) | $2,517,000 (26.48%) | $1,990,000 (44.31%) | $1,379,000 (-0.65%) |
Interest Expense | $0 (0%) | -$96,000 (-143.24%) | $222,000 (-5.53%) | $235,000 (-31.69%) |
Income Tax Expense | -$3,835,000 (-1142.12%) | $368,000 (194.40%) | $125,000 (101.11%) | -$11,217,000 (-44968.00%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $381,000 (-84.32%) | $2,430,000 (4018.64%) |
Consolidated Income | $14,560,000 (87.05%) | $7,784,000 (5.95%) | $7,347,000 (-46.01%) | $13,609,000 (553.65%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | $14,560,000 (87.05%) | $7,784,000 (5.95%) | $7,347,000 (-46.01%) | $13,609,000 (553.65%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | -$2,046,000 (0%) | $0 (0%) |
Net Income Common Stock | $14,560,000 (87.05%) | $7,784,000 (-17.13%) | $9,393,000 (-30.98%) | $13,609,000 (553.65%) |
Weighted Average Shares | $9,846,000 (2.25%) | $9,629,000 (7.30%) | $8,974,000 (9.27%) | $8,213,000 (1.95%) |
Weighted Average Shares Diluted | $10,327,000 (2.17%) | $10,108,000 (5.57%) | $9,575,000 (5.28%) | $9,095,000 (6.51%) |
Earning Before Interest & Taxes (EBIT) | $10,725,000 (33.13%) | $8,056,000 (4.70%) | $7,694,000 (192.88%) | $2,627,000 (7.18%) |
Gross Profit | $12,664,000 (8.42%) | $11,681,000 (17.49%) | $9,942,000 (54.28%) | $6,444,000 (59.43%) |
Operating Income | $10,287,000 (12.25%) | $9,164,000 (15.24%) | $7,952,000 (57.00%) | $5,065,000 (90.84%) |
CHCI Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$350,000 (77.38%) | -$1,547,000 (26.30%) | -$2,099,000 (-264.50%) | $1,276,000 (-25.07%) |
Net Cash Flow from Financing | -$352,000 (9.74%) | -$390,000 (96.13%) | -$10,068,000 (-4335.24%) | -$227,000 (19.50%) |
Net Cash Flow from Operations | $10,675,000 (18.57%) | $9,003,000 (7.22%) | $8,397,000 (-3.35%) | $8,688,000 (142.75%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $9,973,000 (41.14%) | $7,066,000 (272.30%) | -$4,101,000 (-146.65%) | $8,791,000 (149.67%) |
Net Cash Flow - Business Acquisitions and Disposals | $446,000 (135.74%) | -$1,248,000 (15.27%) | -$1,473,000 (-200.61%) | $1,464,000 (-19.47%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$368,000 (-48.99%) | -$247,000 (60.54%) | -$626,000 (-232.98%) | -$188,000 (-63.48%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | -$5,500,000 (-109900.00%) | -$5,000 (97.81%) |
Issuance (Purchase) of Equity Shares | $226,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $945,000 (-2.38%) | $968,000 (16.07%) | $834,000 (31.75%) | $633,000 (-9.70%) |
Depreciation Amortization & Accretion | $302,000 (42.45%) | $212,000 (2.91%) | $206,000 (119.15%) | $94,000 (-6.00%) |
CHCI Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 24.70% (-5.36%) | 26.10% (3.16%) | 25.30% (22.22%) | 20.70% (15.00%) |
Profit Margin | 28.40% (63.22%) | 17.40% (-27.20%) | 23.90% (-45.43%) | 43.80% (370.97%) |
EBITDA Margin | 21.50% (16.22%) | 18.50% (-7.96%) | 20.10% (128.41%) | 8.80% (-22.12%) |
Return on Average Equity (ROAE) | 34.00% (44.07%) | 23.60% (-32.95%) | 35.20% (-44.74%) | 63.70% (207.73%) |
Return on Average Assets (ROAA) | 27.40% (54.80%) | 17.70% (-23.04%) | 23.00% (-34.66%) | 35.20% (270.53%) |
Return on Sales (ROS) | 20.90% (16.11%) | 18.00% (-8.16%) | 19.60% (133.33%) | 8.40% (-22.94%) |
Return on Invested Capital (ROIC) | 31.10% (35.22%) | 23.00% (6.48%) | 21.60% (195.89%) | 7.30% (-39.17%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | 5.46 (-0.22%) | 5.47 (35.15%) | 4.05 (38.54%) | 2.92 (-76.03%) |
Price to Sales Ratio (P/S) | 1.55 (62.58%) | 0.95 (-1.65%) | 0.97 (-24.28%) | 1.28 (12.76%) |
Price to Book Ratio (P/B) | 1.53 (32.81%) | 1.15 (-17.63%) | 1.4 (-12.54%) | 1.59 (-30.20%) |
Debt to Equity Ratio (D/E) | 0.24 (-30.12%) | 0.34 (-27.54%) | 0.47 (-34.81%) | 0.72 (-53.23%) |
Earnings Per Share (EPS) | 1.48 (82.72%) | 0.81 (-22.86%) | 1.05 (-36.75%) | 1.66 (538.46%) |
Sales Per Share (SPS) | 5.21 (12.19%) | 4.64 (6.00%) | 4.38 (15.72%) | 3.79 (35.65%) |
Free Cash Flow Per Share (FCFPS) | 1.05 (15.18%) | 0.91 (4.97%) | 0.87 (-16.33%) | 1.03 (140.70%) |
Book Value Per Share (BVPS) | 5.32 (37.62%) | 3.87 (20.22%) | 3.21 (4.38%) | 3.08 (121.26%) |
Tangible Assets Book Value Per Share (TABVPS) | 6.57 (27.13%) | 5.17 (9.62%) | 4.72 (-11.15%) | 5.31 (49.63%) |
Enterprise Value Over EBIT (EV/EBIT) | 6 (20.00%) | 5 (0.00%) | 5 (-70.59%) | 17 (54.55%) |
Enterprise Value Over EBITDA (EV/EBITDA) | 5.93 (25.07%) | 4.74 (-10.82%) | 5.31 (-67.38%) | 16.29 (55.88%) |
Asset Turnover | 0.97 (-4.83%) | 1.01 (5.51%) | 0.96 (19.65%) | 0.8 (-21.48%) |
Current Ratio | 5.52 (44.25%) | 3.83 (57.38%) | 2.43 (-26.60%) | 3.31 (21.01%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | $10,307,000 (17.71%) | $8,756,000 (12.68%) | $7,771,000 (-8.58%) | $8,500,000 (145.38%) |
Enterprise Value (EV) | $65,342,346 (66.81%) | $39,170,661 (-6.68%) | $41,974,416 (-5.30%) | $44,323,574 (66.28%) |
Earnings Before Tax (EBT) | $10,725,000 (31.56%) | $8,152,000 (9.10%) | $7,472,000 (212.37%) | $2,392,000 (13.53%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | $11,027,000 (33.37%) | $8,268,000 (4.66%) | $7,900,000 (190.33%) | $2,721,000 (6.66%) |
Invested Capital | $35,580,000 (12.02%) | $31,761,000 (-0.85%) | $32,033,000 (-7.36%) | $34,579,000 (13.45%) |
Working Capital | $30,072,000 (66.95%) | $18,013,000 (93.92%) | $9,289,000 (-33.72%) | $14,015,000 (79.17%) |
Tangible Asset Value | $64,723,000 (29.98%) | $49,795,000 (17.64%) | $42,329,000 (-2.92%) | $43,602,000 (52.57%) |
Market Capitalization | $79,903,346 (86.80%) | $42,774,661 (6.28%) | $40,246,416 (-0.27%) | $40,356,574 (57.48%) |
Average Equity | $42,787,750 (29.54%) | $33,030,750 (23.82%) | $26,676,500 (24.94%) | $21,351,750 (112.39%) |
Average Assets | $53,114,250 (20.60%) | $44,042,750 (7.72%) | $40,887,000 (5.73%) | $38,672,750 (76.02%) |
Invested Capital Average | $34,494,750 (-1.38%) | $34,978,250 (-1.61%) | $35,551,250 (-1.48%) | $36,084,000 (76.12%) |
Shares | 9,889,028 (2.46%) | 9,651,758 (1.92%) | 9,469,745 (13.81%) | 8,320,943 (2.93%) |
